517 related articles for article (PubMed ID: 28497941)
41. Efficacy of magnesium-amiodarone step-up scheme in critically ill patients with new-onset atrial fibrillation: a prospective observational study.
Sleeswijk ME; Tulleken JE; Van Noord T; Meertens JH; Ligtenberg JJ; Zijlstra JG
J Intensive Care Med; 2008; 23(1):61-6. PubMed ID: 18320707
[TBL] [Abstract][Full Text] [Related]
42. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.
Budeus M; Hennersdorf M; Perings S; Röhlen S; Schnitzler S; Felix O; Reimert K; Feindt P; Gams E; Lehmann N; Wieneke H; Sack S; Erbel R; Perings C
Eur Heart J; 2006 Jul; 27(13):1584-91. PubMed ID: 16760210
[TBL] [Abstract][Full Text] [Related]
43. Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial.
Madrid AH; Escobar C; Rebollo JM; Marín I; Bernal E; Nannini S; Limón L; Peng J; Moro C
Card Electrophysiol Rev; 2003 Sep; 7(3):243-6. PubMed ID: 14739722
[TBL] [Abstract][Full Text] [Related]
44. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.
Kosior DA; Opolski G; Wozakowska-Kaplon B; Rabczenko D;
Cardiology; 2005; 104(1):35-44. PubMed ID: 15942183
[TBL] [Abstract][Full Text] [Related]
45. Pharmacologic management of atrial fibrillation: established and emerging options.
Kalus JS
J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
[TBL] [Abstract][Full Text] [Related]
46. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol.
Skiba MA; Pick AW; Chaudhuri K; Bailey M; Krum H; Kwa LJ; Rosenfeldt FL
Heart Lung Circ; 2013 Aug; 22(8):627-33. PubMed ID: 23465653
[TBL] [Abstract][Full Text] [Related]
47. Amiodarone for the restoration of sinus rhythm in patients with atrial fibrillation.
Vardas PE; Kochiadakis GE
Card Electrophysiol Rev; 2003 Sep; 7(3):297-9. PubMed ID: 14739732
[TBL] [Abstract][Full Text] [Related]
48. Amiodarone in atrial fibrillation.
Levy S
Int J Clin Pract; 1998 Sep; 52(6):429-31. PubMed ID: 9894383
[TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
Beatch GN; Mangal B
BMC Cardiovasc Disord; 2016 May; 16():113. PubMed ID: 27233239
[TBL] [Abstract][Full Text] [Related]
50. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs.
Balla I; Petrela E; Kondili A
Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317
[TBL] [Abstract][Full Text] [Related]
51. The efficacy and safety of intraoperative intravenous amiodarone in patients undergoing on-pump coronary artery bypass grafting surgery: a systemic review and PRISMA-compliant meta-analysis.
Deng JH; Jia B; Yao YT;
J Cardiothorac Surg; 2024 May; 19(1):274. PubMed ID: 38702789
[TBL] [Abstract][Full Text] [Related]
52. Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review.
Dagres N; Iliodromitis EK; Lekakis JP; Simitsis P; Karatzas D; Rallidis LS; Simeonidou E; Anastasiou-Nana M
J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):254-9. PubMed ID: 24662415
[TBL] [Abstract][Full Text] [Related]
53. Frontal plane QRS-T angle in the monitoring of intravenous amiodarone infusion for pharmacological cardioversion of acute atrial fibrillation.
Eyuboglu M
J Clin Pharm Ther; 2021 Jun; 46(3):731-737. PubMed ID: 33340427
[TBL] [Abstract][Full Text] [Related]
54. Practical regimen for amiodarone use in preventing postoperative atrial fibrillation.
Zebis LR; Christensen TD; Thomsen HF; Mikkelsen MM; Folkersen L; Sørensen HT; Hjortdal VE
Ann Thorac Surg; 2007 Apr; 83(4):1326-31. PubMed ID: 17383335
[TBL] [Abstract][Full Text] [Related]
55. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
Mooss AN; Wurdeman RL; Sugimoto JT; Packard KA; Hilleman DE; Lenz TL; Rovang KS; Arcidi JM; Mohiuddin SM
Am Heart J; 2004 Oct; 148(4):641-8. PubMed ID: 15459595
[TBL] [Abstract][Full Text] [Related]
56. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study.
Vardas PE; Kochiadakis GE; Igoumenidis NE; Tsatsakis AM; Simantirakis EN; Chlouverakis GI
Chest; 2000 Jun; 117(6):1538-45. PubMed ID: 10858380
[TBL] [Abstract][Full Text] [Related]
57. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
Singh SN; Tang XC; Reda D; Singh BN
Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
[TBL] [Abstract][Full Text] [Related]
58. Intravenous and oral amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass surgery.
Turk T; Ata Y; Vural H; Ozkan H; Yavuz S; Ozyazicioglu A
Heart Surg Forum; 2007; 10(4):E299-303. PubMed ID: 17599879
[TBL] [Abstract][Full Text] [Related]
59. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
[TBL] [Abstract][Full Text] [Related]
60. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
